Correlation Between Gain Therapeutics and Zenith Capital
Can any of the company-specific risk be diversified away by investing in both Gain Therapeutics and Zenith Capital at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Gain Therapeutics and Zenith Capital into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Gain Therapeutics and Zenith Capital Corp, you can compare the effects of market volatilities on Gain Therapeutics and Zenith Capital and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Gain Therapeutics with a short position of Zenith Capital. Check out your portfolio center. Please also check ongoing floating volatility patterns of Gain Therapeutics and Zenith Capital.
Diversification Opportunities for Gain Therapeutics and Zenith Capital
-0.12 | Correlation Coefficient |
Good diversification
The 3 months correlation between Gain and Zenith is -0.12. Overlapping area represents the amount of risk that can be diversified away by holding Gain Therapeutics and Zenith Capital Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zenith Capital Corp and Gain Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Gain Therapeutics are associated (or correlated) with Zenith Capital. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zenith Capital Corp has no effect on the direction of Gain Therapeutics i.e., Gain Therapeutics and Zenith Capital go up and down completely randomly.
Pair Corralation between Gain Therapeutics and Zenith Capital
Given the investment horizon of 90 days Gain Therapeutics is expected to under-perform the Zenith Capital. But the stock apears to be less risky and, when comparing its historical volatility, Gain Therapeutics is 33.01 times less risky than Zenith Capital. The stock trades about -0.21 of its potential returns per unit of risk. The Zenith Capital Corp is currently generating about 0.19 of returns per unit of risk over similar time horizon. If you would invest 8.00 in Zenith Capital Corp on September 1, 2024 and sell it today you would earn a total of 3.00 from holding Zenith Capital Corp or generate 37.5% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 95.45% |
| Values | Daily Returns |
Gain Therapeutics vs. Zenith Capital Corp
Performance |
| Timeline |
| Gain Therapeutics |
| Zenith Capital Corp |
Gain Therapeutics and Zenith Capital Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Gain Therapeutics and Zenith Capital
The main advantage of trading using opposite Gain Therapeutics and Zenith Capital positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Gain Therapeutics position performs unexpectedly, Zenith Capital can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zenith Capital will offset losses from the drop in Zenith Capital's long position.| Gain Therapeutics vs. Tff Pharmaceuticals | Gain Therapeutics vs. Eliem Therapeutics | Gain Therapeutics vs. Inhibrx | Gain Therapeutics vs. Enliven Therapeutics |
| Zenith Capital vs. Rigel Pharmaceuticals | Zenith Capital vs. Geron | Zenith Capital vs. Verastem | Zenith Capital vs. Immutep Ltd ADR |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Stocks Directory Find actively traded stocks across global markets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |